Our Story
The Translational Research Cancer Centers Consortium was initiated in 1998 to expedite progress in immunotherapy and biologic therapies. By uniting leaders in the field, TRCCC fosters collaboration and innovation in cancer research.
Translational Research Cancer Center Consortium
EIN: 83-1794049 · Pittsburgh, PA
Cancer Immunotherapy
Biologic Therapies
Our Impact
TRCCC aims to deepen the understanding of immune system interactions with cancer, enhancing biologic therapy outcomes and contributing to groundbreaking advancements in cancer treatment.
Why Donate?
Your donations support TRCCC's mission to advance cancer immunotherapy research, providing essential resources for clinical trials, scholarships, and awards.
Make a Difference Today
Join the fight against cancer by donating cryptocurrency or cash to TRCCC. Your contribution can help transform lives and advance critical research in cancer treatment.
Do you represent Translational Research Cancer Center Consortium? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.